“Psilocybin, the active ingredient in psychedelic mushrooms, has shown promise in limited early studies, not only in alcohol and harder drugs, but also nicotine — all of which resist long term treatment.” This article in The New York Times delves into some promising new research about the ability of psilocybin to help treat different forms of addiction, and reiterates the importance that psychedelic-assisted therapy should take place within the framework of legitimate research studies and/or under appropriate medical supervision. #
The Next Big Addiction Treatment
